JP2010509937A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509937A5
JP2010509937A5 JP2009538451A JP2009538451A JP2010509937A5 JP 2010509937 A5 JP2010509937 A5 JP 2010509937A5 JP 2009538451 A JP2009538451 A JP 2009538451A JP 2009538451 A JP2009538451 A JP 2009538451A JP 2010509937 A5 JP2010509937 A5 JP 2010509937A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
antigen
variable region
cell line
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009538451A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509937A (ja
Filing date
Publication date
Priority claimed from US11/562,759 external-priority patent/US7488807B2/en
Application filed filed Critical
Publication of JP2010509937A publication Critical patent/JP2010509937A/ja
Publication of JP2010509937A5 publication Critical patent/JP2010509937A5/ja
Withdrawn legal-status Critical Current

Links

JP2009538451A 2006-11-22 2007-11-15 プロテインａ選択性を有する抗体 Withdrawn JP2010509937A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/562,759 US7488807B2 (en) 2006-11-22 2006-11-22 Antibody with protein A selectivity
PCT/US2007/084736 WO2008140570A2 (en) 2006-11-22 2007-11-15 Antibody with protein a selectivity

Publications (2)

Publication Number Publication Date
JP2010509937A JP2010509937A (ja) 2010-04-02
JP2010509937A5 true JP2010509937A5 (cg-RX-API-DMAC7.html) 2011-01-06

Family

ID=39417386

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009538451A Withdrawn JP2010509937A (ja) 2006-11-22 2007-11-15 プロテインａ選択性を有する抗体

Country Status (4)

Country Link
US (2) US7488807B2 (cg-RX-API-DMAC7.html)
EP (1) EP2087003A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010509937A (cg-RX-API-DMAC7.html)
WO (1) WO2008140570A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008140581A2 (en) 2006-11-22 2008-11-20 3M Innovative Properties Company Systems and methods for preparing and analyzing samples
WO2008136861A2 (en) * 2006-11-22 2008-11-13 3M Innovative Properties Company Inactivated and dried biological preparations
US8597959B2 (en) * 2007-04-19 2013-12-03 3M Innovative Properties Company Methods of use of solid support material for binding biomolecules
WO2009009188A2 (en) * 2007-04-19 2009-01-15 3M Innovative Properties Company Uses of water-dispersible silica nanoparticles for attaching biomolecules
JP2011504236A (ja) * 2007-11-20 2011-02-03 スリーエム イノベイティブ プロパティズ カンパニー ジアセチレンを含むポリマーセンサーを用いる細菌試料の分析方法
HRP20160274T1 (hr) 2009-04-03 2016-04-08 University Of Chicago Pripravci i metode vezane za varijante proteina a (spa)
ES2655701T3 (es) 2010-07-02 2018-02-21 The University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
CN103906535B (zh) 2011-08-15 2017-07-14 芝加哥大学 与葡萄球菌蛋白a的抗体相关的组合物和方法
EP2793944B1 (en) 2011-12-23 2025-10-08 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
MX355107B (es) 2014-06-03 2018-04-04 Xbiotech Inc Composiciones y metodos para tratar y prevenir infecciones por staphylococcus aureus.
AU2019384790A1 (en) * 2018-11-21 2021-03-18 Regeneron Pharmaceuticals, Inc. Anti-staphylococcus antibodies and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB8426463D0 (en) 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
JPS63273495A (ja) 1987-04-30 1988-11-10 Sekisui Chem Co Ltd 抗プロテインａ単クロ−ン性抗体とその製法，および該抗体を用いるプロテインａの測定方法
DE68927933T2 (de) 1988-09-02 1997-08-14 Dyax Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5750373A (en) 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
EP0585287B1 (en) 1990-07-10 1999-10-13 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
AU1545692A (en) 1991-03-01 1992-10-06 Protein Engineering Corporation Process for the development of binding mini-proteins
US5658727A (en) 1991-04-10 1997-08-19 The Scripps Research Institute Heterodimeric receptor libraries using phagemids
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US6008341A (en) * 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US6994855B1 (en) * 1994-08-22 2006-02-07 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US5594116A (en) * 1995-11-08 1997-01-14 Promega Corporation Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay
FR2746398B1 (fr) * 1996-03-21 1998-04-30 Bio Merieux Anticorps specifique de staphylococcus aureaus, et utilisations
EP2339344A1 (en) * 2001-06-15 2011-06-29 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
WO2003059935A2 (en) * 2001-12-21 2003-07-24 Immunex Corporation Methods for purifying protein
AU2003284643A1 (en) * 2002-11-22 2004-06-18 Daiichi Pure Chemicals Co., Ltd. Method of examining staphylococcus aureus
EP2095123A2 (en) * 2006-11-22 2009-09-02 3M Innovative Properties Company Fluidic antibody-containing devices and methods

Similar Documents

Publication Publication Date Title
JP2010509937A5 (cg-RX-API-DMAC7.html)
JP2010513228A5 (cg-RX-API-DMAC7.html)
HRP20201634T1 (hr) Monoklonsko protutijelo protiv interleukina-31
CA2953714C (en) Anti-tnfa antibodies with ph-dependent antigen binding
JP2013198490A5 (cg-RX-API-DMAC7.html)
PE20110801A1 (es) Anticuerpos con reactividad cruzada y biespecificos anti-il-17a/f
NZ595464A (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
NZ597023A (en) Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
WO2013037484A3 (en) Anti-aplhabetatcr antibody
JP2015028021A5 (cg-RX-API-DMAC7.html)
FI3683235T3 (fi) Anti-IL-33-vasta-aineita ja niiden käyttöjä
NO20074867L (no) Antistoffer mot CCR5 og anvendelser derav
EA201190132A1 (ru) Гуманизированные антитела, связывающиеся с cd19, и их применение
RU2017128882A (ru) Антитела к биотину и способы их применения
EA201990673A1 (ru) Антитела, специфически связывающиеся с il-17a, и их функциональные фрагменты
RU2014100111A (ru) МОЛЕКУЛЫ, СВЯЗЫВАЮЩИЕСЯ С Psl Pseudomonas, И ПУТИ ИХ ПРИМЕНЕНИЯ
HRP20140266T1 (hr) Postupci inhibiranja vezanja endosijalina na ligande
WO2008143697A3 (en) Antibody with protein a selectivity
WO2008140570A3 (en) Antibody with protein a selectivity
JP2018507254A5 (cg-RX-API-DMAC7.html)
MX2016004928A (es) Secuencias de anticuerpos con reaccion cruzada para staphylococcus aureus.
JP2017518260A5 (cg-RX-API-DMAC7.html)
RU2015121617A (ru) Способы лечения заболеваний, ассоциированных с s. aureus
JP2011509650A5 (cg-RX-API-DMAC7.html)
JP2017506064A5 (cg-RX-API-DMAC7.html)